Beta-Thalassemia Recruiting Phase 3 Trials for Luspatercept (DB12281)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04064060A Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsTreatment